Related Experiment Video
Updated: May 29, 2026

P50 Sensory Gating in Infants
Published on: December 26, 2013
Sedation for children 2 to 5 years of age undergoing auditory brainstem response and auditory steady state responses
Martine François1, Natacha Teissier, Gwladys Barthod
1ENT Department, Robert Debré Hospital, Paris, France. francois.martine@laposte.net
Insights
Sedation using intrarectal pentobarbital and oral alimemazine is a feasible alternative for auditory brain stem response (ABR) and auditory steady-state response (ASSR) recordings in young children. This method successfully enabled testing in 89.8% of non-napping children, avoiding general anesthesia.
Area of Science:
- Pediatric audiology
- Neurophysiology
- Pharmacology
Background:
- Auditory brain stem responses (ABR) and auditory steady-state responses (ASSR) are crucial for assessing hearing in young children.
- Behavioral testing is often not feasible in children aged 2-5 years due to developmental delays or behavioral issues.
- General anesthesia is a common but resource-intensive method for audiological testing in uncooperative children.
Purpose of the Study:
- To assess the feasibility, duration, and outcomes of sedation using intrarectal pentobarbital and oral alimemazine.
- To evaluate the effectiveness of this sedation protocol for ABR and ASSR recordings in children aged 2-5 years.
- To determine if this sedation method is a viable alternative to general anesthesia.
Main Methods:
- A prospective study involving 180 children aged 2-5 years who required ABR and ASSR testing.
- Children who did not nap spontaneously received sedation with intrarectal pentobarbital, optionally potentiated by oral alimemazine.
- Data collected included sedation success rates, time to sleep, and recording duration.
Main Results:
- Only 23 children (12.8%) achieved a spontaneous nap.
- Sedation was administered to 157 children (72 with pentobarbital alone, 85 with both agents).
- Recordings were successfully completed in 89.8% of sedated children, with average recording times of 20 minutes for ABR and 25 minutes for ASSR.
Conclusions:
- Intrarectal pentobarbital, with or without oral alimemazine, is a feasible and effective sedation method for pediatric ABR and ASSR.
- This sedation approach allows for successful audiological testing in a high percentage of children who do not nap.
- It presents a valuable alternative to general anesthesia, potentially reducing costs and risks.
Objective:
To evaluate the feasibility, the duration and results of sedation by intrarectal pentobarbital and oral alimemazine for auditory brain stem responses (ABR) and auditory steady-state responses (ASSR) recordings in children aged 2 to 5 years.
Design:
Prospective study.
Study Sample:
180 consecutive children aged 2 to 5 years, referred for language retardation and/or behavioral problems, who could not be tested by behavioral methods, underwent ABR and ASSR recordings. The children who did not spontaneously nap were sedated by intrarectal pentobarbital eventually potentiated by oral alimemazine.
Results:
A spontaneous nap was obtained in only 23 cases, 72 children received only pentobarbital, and 85 received both pentobarbital and alimemazine. Even so, recording was impossible in 16 cases, and interrupted before completion of the ASSR recordings in 45 cases. Children went to sleep in average 64 min +/- 40. The average recording time for the ABR was 20 minutes, and for the ASSR 25 minutes.
Conclusion:
Sedation by pentobarbital, eventually completed by oral alimemazine, allows ABR and/or ASSR recordings in 89.8% of the children who did not nap in the recording room, and is therefore a good alternative to general anesthesia in these children.
More Related Videos
14:05Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses
Published on: January 23, 2017
08:38Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020